Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Objectives: To demonstrate the safety and efficacy of a 25 mg/ml HA for the management of labia majora deflation.

Introduction: The labia majora plays a vital role in protecting the labia minora.This protection prevents unwanted friction of the labia minora that may cuase pain.
Hypotrophy of the labia majora is a cuase of chronic vulvitis and vulvo vaginal dryness causing discomfort, priritus and intromission dispareunia.

Materials / method: The study was conducted between November 2019-July 2020 . 40 patients with different degree of vulvar ptosis and deflation were recruited.
One single application of a 25 mg/ml HA was performed.
FU were done at 30 - 60 and 90 days with photographic record and Global Aesthetic Improvement Scale (GAIS)

Results: The results were all positive with a complete satisfaction of our patients and there was no need of a touch up.
There were no severe adverse effects from this treatment in any of the patients.

Conclusion: HA in a 25 mg/ml is a safe and effective method to treat this type of patients.

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
No

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work was not supported by any direct or non direct funding. It is under the author's own responsability

Disclosures

Did you receive any funding to support your research for this TOPIC?
No

Were you provided with any honoraria, payment or other compensation for your work on this study?
No

Do you have any financial relationship with any entity which may closely compete with the medications, materials or instruments covered by your study?
Yes
Please specify entities (individual, company, society): company

Do you own or have you applied for any patents in conjunction with the instruments, medications or materials discussed in your study?
No

This work is presented thanks to the support of: temamedicina